Related Experiment Video
Updated: May 19, 2026

Defining Substrate Specificities for Lipase and Phospholipase Candidates
Published on: November 23, 2016
Structural basis of substrate specificity and selectivity of murine cytosolic 5'-nucleotidase III
Christina L Grobosky1, Jennifer B Lopez, Sarahbeth Rennie
1Department of Chemistry, Georgian Court University, Lakewood, NJ 08701, USA.
Abstract:
Cytosolic 5'-nucleotidase III (cN-III) is responsible for selective degradation of pyrimidine 5'-monoribonucleotides during maturation of reticulocytes to erythrocytes. The lack of this enzymatic activity due to genetic aberrations or lead poisoning results in a mild to moderate nonspherocytic hemolytic anemia. In affected individuals, pyrimidine nucleotides as well as their precursor polymers and their off-path metabolites accumulate in erythrocytes, interfering with their proper function in ways that are not yet fully understood. This report describes the first X-ray structure of a catalytically inactivated variant of murine cN-III with a natural substrate, uridine 5'-monophosphate, in the active site at 1.74Å resolution. The structure captures in an atomic detail the closed conformation that cN-III adopts upon substrate binding. Structure and sequence analysis coupled with enzymatic characterization of several mutants confirmed that the aromatic ring of a nitrogenous base of substrate nucleotide is stabilized by parallel π-stacking interactions with conserved aromatic rings of Trp113 and His68. The nitrogenous base is further stabilized by T-shaped stacking with the conserved aromatic ring of Tyr114, as well as by polar contacts with side chains of Thr66 and Ser117. Two water molecules help to stabilize the nucleotide binding by bridging it to protein residues Asp72 and His68 via hydrogen bonds. Finally, fully conserved Glu96 is responsible for recognition of ribose ring via two hydrogen bonds. The presented substrate complex structure elucidates how cN-III achieves specificity for pyrimidine 5'-nucleotides and how it selects against purine 5'-nucleotides.
Insights
Cytosolic 5'-nucleotidase III (cN-III) deficiency causes hemolytic anemia by preventing pyrimidine nucleotide breakdown. This study reveals the enzyme's structure bound to uridine 5'-monophosphate, explaining its specificity.
Area of Science:
- Biochemistry
- Structural Biology
- Enzymology
Background:
- Cytosolic 5 -nucleotidase III (cN-III) selectively degrades pyrimidine 5 -monoribonucleotides during red blood cell maturation.
- Deficiency in cN-III activity leads to nonspherocytic hemolytic anemia due to pyrimidine nucleotide accumulation in erythrocytes.
- The precise mechanisms of cN-III substrate specificity and its role in erythrocyte function remain incompletely understood.
Purpose of the Study:
- To determine the first X-ray structure of a catalytically inactivated murine cN-III variant bound to its natural substrate, uridine 5 -monophosphate.
- To elucidate the atomic details of the enzyme-substrate complex and understand the molecular basis for cN-III's specificity.
- To investigate the role of specific amino acid residues and interactions in substrate recognition and binding.
Main Methods:
- X-ray crystallography of a catalytically inactivated murine cN-III variant.
- Co-crystallization with uridine 5 -monophosphate.
- Structure determination at 1.74Å resolution.
- Structure and sequence analysis coupled with enzymatic characterization of mutant variants.
Main Results:
- The X-ray structure reveals a closed conformation of cN-III upon binding uridine 5 -monophosphate.
- Specific interactions, including π-stacking with Trp113 and His68, T-shaped stacking with Tyr114, and polar contacts with Thr66 and Ser117, stabilize the nucleotide's nitrogenous base.
- Hydrogen bonds involving two water molecules and residues Asp72 and His68, along with interactions with Glu96 for ribose recognition, are crucial for nucleotide binding.
- The structure provides atomic-level insights into cN-III's specificity for pyrimidine 5 -nucleotides over purine 5 -nucleotides.
Conclusions:
- The determined structure provides a detailed molecular explanation for cN-III's selective degradation of pyrimidine 5 -monoribonucleotides.
- Understanding these interactions is key to comprehending the pathogenesis of cN-III deficiency-related hemolytic anemia.
- This structural information can guide future research on enzyme function and the development of therapeutic strategies.
Related Concept Videos
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Transfer RNA Synthesis
Each of these chemical modifications is carried by a specific enzyme, post-transcription. All of these enzymes have unique base and site-specificity. Methylation, the most common chemical modification, is carried by at least nine different enzymes, with...
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Induced-fit Model
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical characteristics of...
Introduction to Mechanisms of Enzyme Catalysis
Ligand Binding and Linkage

